Caixin
Caixin Global – Latest China News & Headlines

Home >

ABOUT US

CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

LATEST
Air Taxi Developer’s Listing Shows Tencent Can’t Shake Its Flying Car Dreams
Apple Hopes Cheaper IPhones Will Woo Chinese Customers
Two Chinese Tech Stocks Sizzle on Latest Hot Concept in Virtual Reality
China Tech Stocks Stumble in Rush Back Toward Bull Market
WeRide Joins With Carmaker, Courier to Commercialize Self-Driving Delivery Vans
JD.com-Backed Dada’s Autonomous Delivery Investment Undercuts Revenue Jump
Non-Innovative Medtech Companies Are Winning Too Much Venture Capital, Official Says
Chipmaker SMIC Inks Deal With Shanghai for $8.8 Billion Factory
Tech Insider: EV Sales a Mixed Bag, MediaTek Stays on Top, Xiaomi’s New Direction
BGI’s Gene Sequencer Spin-Off Approved for Shanghai IPO
Smartphone Giant Xiaomi Officially Revs Up Smart Car Business
China’s GPS Alternative Gets Regulatory Roadmap in Push to Boost Adoption
Meituan Faces Fresh Regulatory Trouble Over Mobike Acquisition
China Hammers Mobile Gaming Industry With Tough New Limits
ByteDance Acquires China’s Largest Virtual Reality Headset Maker
Microchip Design Specialist Arm China Takes a Turn Into Autonomous Driving
Tech Insider: Self-Flying Hopeful EHang Runs Into Turbulence, Chipmaker Arm China Joins Auto Drive, iQiyi Gives Up on Its Idols
Self-Flying Vehicle Specialist EHang Hits Earnings Turbulence
Volvo to Buy Chinese Truck Manufacturer to Capitalize on Delivery Boom
Douyin Removes User Clips After Backing Down From Copyright Showdown With Tencent Video
Bota Bio Raises New Capital to Popularize Biological Manufacturing

By Ding Yi / Jul 30, 2021 07:13 PM / Business & Tech

Chinese industrial biotech startup Bota Bio has raised more than $100 million in a series B funding round, bringing its total financing to $145 million.

Founded in 2019 in Hangzhou, the firm specializes in using microorganisms and biological components to manufacture common household and industrial products, with a vision to make traditional manufacturing processes more sustainable.

Led by Sequoia Capital China, the round attracted investors including Matrix Partners China, Source Code Capital, Sherpa Healthcare Partners and 5Y Capital, Bota Bio said in a statement on Thursday.

The company said that it intends to use the fresh capital to expand its global operations and build a technology platform which will accelerate the deployment of its product pipeline involving consumer goods, food, nutrition and pharmaceutical products.

“We are empowering a diverse global client base from different industries to develop bio-based alternatives to traditional ingredients,” said Bota Bio CEO Cheryl Cui.

She added that her company’s solutions could help manufacturers achieve a transition to eco-friendly operations as governments worldwide undertake ambitious plans to go carbon neutral.

In March, Bota Bio received investment from German chemical producer BASF’s BASF Venture Capital.

Related: Chinese Drugmaker Inmagene Secures $100 Million in New Funding

Contact reporter Ding Yi (yiding@caixin.com) and editor Heather Mowbray (heathermowbray@caixin.com)

Share this article
Open WeChat and scan the QR code